SCHEMBL8828501

SCHEMBL8828501

CN(C)C(=O)c1ccccc1NCCCCl

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
KDM4E B2RXH2 1/20 0.44
GLA P06280 1/20 0.44
POLB P06746 1/20 0.44
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CXCR2 P25025 3/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGS2 P35354 1/20 0.41
DRD2 P14416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28454558 0.83 ADRA1A (0.53) ADRA1DADRA1AADRA1BKDM4EGLA
SCHEMBL28618228 0.80 KDM4E (0.69) ADRA1DADRA1AADRA1BKDM4EGLA
SCHEMBL8691774 0.80 AGTR1 (0.52) KDM4EGLAALDH1A1HPGDHSD17B10
SCHEMBL28455283 0.79 ADRA1D (0.56) ADRA1DADRA1AADRA1BKDM4EGLA
SCHEMBL8828665 0.78 ADRA1D (0.44) ADRA1DADRA1AADRA1BKDM4EGLA
SCHEMBL29212431 0.75 ADRA1D (0.52) ADRA1DADRA1AADRA1BKDM4EGLA
SCHEMBL8828526 0.74 LRRK2 (0.40) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL8343253 0.73 POLB (0.58) ADRA1DADRA1AADRA1BKDM4EPOLB
SCHEMBL6361780 0.72 MEN1 (0.50) ADRA1DADRA1AADRA1BPOLBALDH1A1
SCHEMBL3685489 0.71 KDM4E (0.49) KDM4EGLAPOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688795-A URINARY TRACTS OBSTRUCTION SYNTEX (U.S.A.) INC. (US) 1997-11-18 US disclosed
EP-0711757-A1 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy -pyridine, pyrimidine and benzene derivatives as alpha1-adrenoceptor antagonists F. Hoffmann-La Roche AG (CH) 1996-05-15 EP disclosed